SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018435
Filing Date
2023-05-08
Accepted
2023-05-05 21:44:29
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-20230331.htm   iXBRL 10-Q 2091203
2 EX-10.4 etnb-ex10_4.htm EX-10 375190
3 EX-31.1 etnb-ex31_1.htm EX-31 19245
4 EX-31.2 etnb-ex31_2.htm EX-31 19257
5 EX-32 etnb-ex32.htm EX-32 21079
  Complete submission text file 0000950170-23-018435.txt   8571870

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT etnb-20230331.xsd EX-101.SCH 50476
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT etnb-20230331_lab.xml EX-101.LAB 460578
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT etnb-20230331_cal.xml EX-101.CAL 52346
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT etnb-20230331_pre.xml EX-101.PRE 318989
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT etnb-20230331_def.xml EX-101.DEF 185903
51 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20230331_htm.xml XML 1584827
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 23895694
SIC: 2834 Pharmaceutical Preparations